GlassScriptPhysician profile
Mohammad Al-Nsour
NPI 1821075086
$992.75
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $544 · 2021: $31.80 · 2022: $43.80 · 2024: $373.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $356 · Education: $17.02.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $356.37 |
| Education | $17.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $220.75 | 2019-2024 | |
| Medtronic, INC. | $137.83 | 2024 | Visualase |
| Merck Sharp & Dohme LLC | $133.17 | 2019 | |
| Boston Scientific Corporation | $68.54 | 2024 | Spyglass |
| Novartis Pharmaceuticals Corporation | $47.68 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $45.05 | 2019 | |
| Pfizer INC. | $44.15 | 2019-2021 | |
| Astellas Pharma US INC | $44.01 | 2019 | |
| Emd Serono, INC. | $43.80 | 2022 | |
| Rigel Pharmaceuticals, INC. | $35.51 | 2019 | |
| Dendreon Pharmaceuticals LLC | $34.36 | 2019 | |
| Exelixis INC. | $34.05 | 2019 | |
| Janssen Biotech, INC. | $24.92 | 2019 | |
| Lilly USA, LLC | $23.16 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $17.02 | 2024 | Libtayo |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $14.26 | 2019 | |
| Pharmacyclics LLC, An Abbvie Company | $13.36 | 2019 | |
| Seagen INC. | $11.13 | 2019 |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohammad Al-Nsour listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.